Subscribe to Scrip Today

Scrip World Pharmaceutical News is more than just a news service. Delivering an unrivalled range of pharma market intelligence, Scrip's network of experienced, locally based journalists provide you with a truly international and independent perspective. From drug manufacturers to CROs, biotech companies to regulators, Scrip subscribers know the value of the unbiased, independent pharmaceutical business intelligence that only Scrip provides.

New for 2008: the Scrip News and Analysis service gives you:  Executive Briefings – every month, senior analysts, leading experts and journalists write an in-depth report which provides you with high-level strategic intelligence on key areas such as: - Regional markets – North America, Europe, Asia and emerging markets - Drug markets such as oncology, cardiology, CNS and metabolic diseases  - Business development activities such as M&A, licensing, regulation and distribution  Market Insights – every issue contains a critical review of key drug market sectors, companies and clinical developments giving you insight into specific areas such as: - The latest therapeutics advances in diabetes - Analysis of market trends and geographic growth - Regulatory decision-making - The development of key sectors - New technologies - Company profiles - Analysis of government policy on healthcare Pipeline Watch – tracking 7,000 drugs in the R&D pipeline: every month you receive up-to-date data on your competitors’ R&D activity in the critical final stage of clinical development. Plus complete coverage of the biopharma industry including: Twice weekly issues of Scrip in the new user friendly format, available as print or PDF   Daily email headlines, now with stories grouped by region and market Policy & Regulation News – keeping you fully briefed on activities of the national agencies around the world including the US FDA and Europe’s EMEA, and providing you with the latest political moves affecting your industry. Business News – from start-ups to multinationals, we cover it all. - Mergers, acquisitions & joint ventures  - Investments & restructuring - Financial results & rankings - Patent & other legal disputes - Marketing strategies  - Licensing activity Research & Development News – covering all significant developments including: - Launches, withdrawals & approvals - New formulations & delivery systems - Therapy profiles - Clinical trial updates The searchable News on the Web function of Scrip allows you to search any of Scrip’s stories as far back as 1995. Bespoke Scrip supplements – in-depth coverage of the hottest topics covering sectors such as drug delivery, biotechnology and key pharma conferences Access to additional online stories not published in the twice weekly print and PDF issues Plus two business intelligence reports - The Scrip Yearbook and Scrip Pharmaceutical Companies League Table - Worth over £3000

Order Scrip Today - simply click on the currency you need

Available currencies PDF and Online	£1,995	€3,090	$3,930	¥559,200
Available currencies Print and Online	£1,995	€3,090	$3,930	¥559,200

Click here to order securely online. Please note you will be taken to the Informa Healthcare shopping website in order to process your payment in a secure environment. Your subscription also comes with a money back guarantee – if you are not completely satisfied with Scrip, we guarantee a full refund within 30 days.

Three easy ways to place your order: 1. Order online by clicking on the relevant currency above 2. Call +44 (0)20 7017 5540 3. Email your details to scripnews@informa.com and we'll send you an invoice